Concepedia

Xiyun Chai

XC

12

Publications

5.8K

Citations

11

H-Index

2004

Active since

Affiliations

Eli Lilly (United States)(Current)

Skåne University Hospital

Lund University

University College London

University of Gothenburg

Xiyun Chai is an author at Eli Lilly (United States) specializing in medicine, neurodegenerative diseases, and neurodegeneration.

Top concepts

Publications per year

2004–2023

12

Publications

12

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz et al. · JAMA · 2020 · 1.4K citations · Full text

Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist et al. · Nature Medicine · 2020 · 1.2K citations

, , +14

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

Elisabeth H. Thijssen, Renaud La Joie, Amy Wolf et al. · Nature Medicine · 2020 · 767 citations · Full text

, , +13

Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography

Michelle M. Mielke, Clinton E. Hagen, Jing Xu et al. · Alzheimer s & Dementia · 2018 · 643 citations

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease

Shorena Janelidze, Erik Stomrud, Ruben Smith et al. · Nature Communications · 2020 · 437 citations · Full text

Rows per page

1–5 of 12